PL EN


Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
Powiadomienia systemowe
  • Sesja wygasła!
  • Sesja wygasła!
Tytuł artykułu

Stałe nanocząsteczki lipidowe - charakterystyka, zastosowanie i otrzymywanie

Treść / Zawartość
Identyfikatory
Warianty tytułu
EN
Solid lipid nanoparticles - characteristics, application and obtaining
Języki publikacji
PL
Abstrakty
Czasopismo
Rocznik
Strony
960--967
Opis fizyczny
Bibliogr. 41 poz., rys., tabl.
Twórcy
autor
autor
  • Instytut Chemii i Techn. Organicznej, Politechnika Krakowska, Kraków
Bibliografia
  • 1. Müller R.H., Mehnert W., Lucks J.S., et al.: Solid lipid nanoparticles (SLN) - an alternative colloidal carrier system for controlled drug delivery. Eur. J. Pharm. Biopharm. 1995,41,62-69.
  • 2. Silva A.C., et al.: Preparation, characterization and biocompatibility studies on risperidone-loaded solid lipid nanoparticles (SLN): High pressure homogenization versus ultrasound. Colloids and Surfaces B: Biointrfaces 2011 (Article In Press).
  • 3. Almeida A.J., Souto E.: Solid lipid nanoparticles as drug delivery system for peptides and proteins. Adv. Drug Deliv. Rev. 2007, 59,478-490.
  • 4. Küchler S., et al.: Nanoparticles for skin penetration enhancement - A comparison of a dendritic core-multishell-nanotransporter and solid lipid nanoparticles. Eur. J. of Pharm, and Biopharm. 2009, 71, 243-250.
  • 5. Wissing SA, et al.: Solid lipid nanoparticles for parenteral drug delivery. Adv. Drug Deliv. Rev. 2004, 56, 1257-1272.
  • 6. Wissing S.A., Müller R.H.: Cosmetic applications for solid lipid nanoparticles (SLN). International Journal of Pharmaceutics 2003, 254, 65-68.
  • 7. Jee J-P., Lim S-J., et al.: Stabilization of all-trans retinol by loading lipophilic antioxidants in solid lipid nanoparticles. Eur. J. of Pharm, and Biopharm. 2006, 63, 134-139.
  • 8. Weiss J., et al.: Solid Lipid Nanoparticles as Delivery Systems for Bioactive Food Components. Food Biophysics 2008, 3, 146-154.
  • 9. Yang S.C., et al.: Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain. J. Control Release 1999, 59, 299-307.
  • 10. Pandey R., Sharma S., Khuller G.K.: Oral solid lipid nanoparticle-based antitubercular chemotherapy. Tuberculosis 2005, 85,415-20.
  • 11. Sznitowska M., Gajewska M,, Janicki S., et al.: Bioavailability of diazepam from aqueous-organic solution, submicron emulsion and solid lipid nanoparticles after rectal administration in rabbits. Eur. J. Pharm Biopharm. 2001, 52, 159-63.
  • 12. Friedrich I., Reichl S., Müller-Goymann C.C.: Drug release and permeation studies of nanosuspensions based on solidified reverse micellar solutions (SRMS). Int. J. Pharm. 2005, 305, 167-75.
  • 13. Lippacher A., Müller R.H., Mäder K.: Semisolid SLN™ dispersions for topical application: influence of formulation and production parameters on viscoelastic properties. Eur. J. Pharm. Biopharm. 2002, 53, 155-60.
  • 14. Münster U., Nakamura C, Haberland A., et al.: RU 58841-myristate -prodrug development for topical treatment of acne and androgenic alopecia. Pharmazie 2005, 60, 8-12.
  • 15. Jenning V., Gohla S.: Encapsulation of retinoids in solid lipid nanoparticles (SLN). Journal of Microencapsulation 2001, 18(2), 149-158.
  • 16. Gasco M.R.: Method for producing solid lipid microspheres having a narrow size distribution. United States of America Patent 1993.
  • 17. Lippacher A., Muller R.H., Mader K.: Investigation on the viscoelastic properties of lipid based colloidal drug carriers. Int. J. Int. J. Pharm. 2000, 196, 227-230.
  • 18. Mehnert W., Mäder K.: Solid lipid nanoparticles Production, characterization and applications. Advanced Drug Delivery Reviews 2001, 47, 165-196.
  • 19. Müller R.H., Mäder K., Gohla S.: Solid lipid nanoparticles (SLN) for controlled drug delivery-a review of the state of the art. Eur. J. of Pharm. And Biopharm. 2000, 50, 161-177.
  • 20. Gasco M.R.: Method for producing solid lipid microspheres having a narrow size distribution. United States Patent, 1993, 5, 250, 236.
  • 21. Moulik S.P, Paul B.K.: Structure, dynamics and transport properties of microemulsions. Adv. Coll. Interf. Sci. 1998, 78, 99-195.
  • 22. Song Ch., Liu S.: A new healthy sunscreen system for human: Solid lipid nannoparticles as carrier for 3,4,5-trimethoxybenzoylchitin and the improvement by adding Vitamin E. International Journal of Biological Macromolecules 2005, 36, 116-119.
  • 23. Üner M., Yener G.: Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives. International Journal of Nanomedicine 2007, 2 (3), 289-300.
  • 24. Sjörström B., Bergenståhl B.: Preparation of submicron drug particles in lecithin-stabilized o/w emulsions. I. Model studies of the precipitation of cholesteryl acetate. Int. J. Pharm. 1992, 88, 53-62.
  • 25. Siekmann B., Westesen K.: Investigations on solid lipid nanoparticles prepared by precipitation in o/w emulsions. Eur. J. Pharm. Biopharm. 1996, 43, 104-109.
  • 26. Siekmann B., Westesen K.: Melt-homogenized solid lipid nanoparticles stabilized by the nonionic surfactant tyloxapol. I. Preparation and particle size determination. Pharm. Pharmacol. Lett. 1994, 3, 194-197.
  • 27. Müller R.H., Dingler A.: The next generation after the liposomes: solid lipid nanoparticles (SLN, Lipopearls) as dermal carrier in cosmetics. Eurocosmetics 1998,7/8, 19-26.
  • 28. zur Mühlen A., Mehnert W.: Drug release and release mechanism of prednisolone loaded solid lipid nanoparticles. Pharmazie 1998, 53, 552-555.
  • 29. Schwarz C., Freitas C., Mehnert W., Müller R.H.: Sterilisation and physical stability of drug-free and etomidate-loaded solid lipid nanoparticles. Proc. Int. Symp. Control. Release Bioact. Mater. 1995, 22, 766-767.
  • 30. zur Mühlen A., Schwarz C., Mehnert W.: Solid lipid nanoparticles (SLN) for controlled drug delivery - drug release and release mechanism. Eur. J. Pharm. Biopharm. 1998,45, 149-155.
  • 31. Yuan H., et al.: Cellular uptake of solid lipid nanoparticles and cytotoxicity of encapsulated paclitaxel in A549 cancer cells. International Journal of Pharmaceutics 2008, 348, 137-145.
  • 32. Cavalli R., Caputo O., Gasco M.R.: Preparation and characterization of solid lipid nanospheres containing paclitaxel. Eur J Pharm Sci. 2000, 10 (4), 305-309.
  • 33. Miglietta A., et al.: Cellular uptake and cytotoxicity of solid lipid nanospheres (SLN) incorporating doxorubicin or paclitaxel. International Journal of Pharmaceutics 2000, 210, 61 -67.
  • 34. Cavalli R., Caputo O., Gasco M.R.: Solid lipospheres of doxorubicin and idarubicin. Int. J. Pharm. 1993, 89, 9-12.
  • 35. Hu F.Q., et al.: Preparation of solid lipid nanoparticles with clobetasol propionate by a novel solvent diffusion method in aqueous system and physicochemical characterization. International Journal of Pharmaceutics 2002, 239, 121-128.
  • 36. Zhang N., et al.: Lectin-modified solid lipid nanoparticles as carriers for oral administration of insulin. International Journal of Pharmaceutics 2006, 327, 153-159.
  • 37. Westesen K., Bunjes H., Koch M.H.J.: Physicochemical characterization of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potential. J. Control. Release 1997, 48, 223-236.
  • 38. Castro G., et al.: Formation of ion pairing as an alternative to improve encapsulation and stability and to reduce skin irritation of retinoic acid loaded in solid lipid nanoparticles. International Journal of Pharmaceutics 2009, 381, 77 83.
  • 39. Dingier A., Hildebrand G., et al.: Cosmetic antiaging formulation based on vitamin E-loaded solid lipid nanoparticles. Proc. Int. Symp. Control. Release Bioact. Mater. 1998, 25,433-434.
  • 40. Jenning V., Gysler A., Schäfer-Körting M, Gohla S.: Vitamin A loaded solid lipid nanoparticles for topical use: occlusive properties and drug penetration into porcine skin. Eur. J. Pharm. Biopharm. 2000, 49, 211-218.
  • 41. Jenning V, Gysler A., Schäfer-Körting M, Gohla S.: Vitamin A loaded solid lipid nanoparticles for topical application: drug release properties. J. Control. Release 2000, 66, 115-126.
Typ dokumentu
Bibliografia
Identyfikator YADDA
bwmeta1.element.baztech-article-BPP2-0012-0038
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.